Evidence map›Paper›PMID 34365041›Full record

ReviewActa biomaterialia2021

Matrix biophysical cues direct mesenchymal stromal cell functions in immunity.

Sing Wan Wong, Stephen Lenzini, Regina Giovanni, Katherine Knowles, Jae-Won Shin

Open access · greenAbstract readReview
In one paragraph

Review in Acta biomaterialia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Hierarchical TiOJournal of the Royal Society, Interface · 2025
    Article
  7. Mesenchymal stem cell therapy for pulmonary hypertension: an update.Frontiers in bioengineering and biotechnology · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. [Differentiation of stem cells regulated by biophysical cues].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023
    Article
  13. Extracellular vesicle-matrix interactions.Nature reviews. Materials · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sing Wan WongDepartment of Pharmacology and Regenerative Medicine, University of Illinois at Chicago, College of Medicine, Chicago, IL, USA; Department of Biomedical Engineering, University of Illinois at Chicago, College of Medicine, Chicago, IL, USA.
Stephen LenziniDepartment of Pharmacology and Regenerative Medicine, University of Illinois at Chicago, College of Medicine, Chicago, IL, USA; Department of Biomedical Engineering, University of Illinois at Chicago, College of Medicine, Chicago, IL, USA.
Regina GiovanniDepartment of Biomedical Science, University of Illinois College of Medicine, Rockford, IL, USA.
Katherine KnowlesDepartment of Pharmacology and Regenerative Medicine, University of Illinois at Chicago, College of Medicine, Chicago, IL, USA.
Jae-Won ShinDepartment of Pharmacology and Regenerative Medicine, University of Illinois at Chicago, College of Medicine, Chicago, IL, USA; Department of Biomedical Engineering, University of Illinois at Chicago, College of Medicine, Chicago, IL, USA. Electronic address: shinjw@uic.edu.
University of Illinois Chicago · USIllinois College · US

Funding

TRAINING PROGRAM IN LUNG BIOLOGY AND PATHOBIOLOGYT32HL007829 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOLLY MEHTA · 1995 to 2026
$15.6M
Encapsulation of mesenchymal stromal cells in engineered microgels for resolution of lung fibrosisR01HL141255 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHIN, JAE-WON · 2019 to 2023
$2.0M
Engineering microscale hydrogel deposition to direct single stem cell differentiationR01GM141147 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHIN, JAE-WON · 2021 to 2024
$1.9M
Mechanically controlled release of hematopoietic factors from mesenchymal stromal cells for blood regenerationR00HL125884 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHIN, JAE-WON · 2016 to 2018
$747k
Engineering mesenchymal stromal cells to treat muscle fibrosisK99AR079561 · NIAMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WONG, SING-WAN · 2021 to 2022
$197k
NHLBI NIH HHS R00 HL125884NHLBI NIH HHS R01 HL141255NHLBI NIH HHS T32 HL007829NIAMS NIH HHS K99 AR079561NIGMS NIH HHS R01 GM141147
6 · The paper itself

Abstract

Hydrogels have been used to design synthetic matrices that capture salient features of matrix microenvironments to study and control cellular functions. Recent advances in understanding of both extracellular matrix biology and biomaterial design have shown that biophysical cues are powerful mediators of cell biology, especially that of mesenchymal stromal cells (MSCs). MSCs have been tested in many clinical trials because of their ability to modulate immune cells in different pathological conditions. While roles of biophysical cues in MSC biology have been studied in the context of multilineage differentiation, their significance in regulating immunomodulatory functions of MSCs is just beginning to be elucidated. This review first describes design principles behind how biophysical cues in native microenvironments influence the ability of MSCs to regulate immune cell production and functions. We will then discuss how biophysical cues can be leveraged to optimize cell isolation, priming, and delivery, which can help improve the success of MSC therapy for immunomodulation. Finally, a perspective is presented on how implementing biophysical cues in MSC potency assay can be important in predicting clinical outcomes. STATEMENT OF SIGNIFICANCE: Stromal cells of mesenchymal origin are known to direct immune cell functions in vivo by secreting paracrine mediators. This property has been leveraged in developing mesenchymal stromal cell (MSC)-based therapeutics by adoptive transfer to treat immunological rejection and tissue injuries, which have been tested in over one thousand clinical trials to date, but with mixed success. Advances in biomaterial design have enabled precise control of biophysical cues based on how stromal cells interact with the extracellular matrix in microenvironments in situ. Investigators have begun to use this approach to understand how different matrix biophysical parameters, such as fiber orientation, porosity, dimensionality, and viscoelasticity impact stromal cell-mediated immunomodulation. The insights gained from this effort can potentially be used to precisely define the microenvironmental cues for isolation, priming, and delivery of MSCs, which can be tailored based on different disease indications for optimal therapeutic outcomes.

Indexed as

Mesenchymal Stem CellsCell DifferentiationCuesExtracellular MatrixImmunomodulationBiomaterialsImmunomodulationMechanomedicineMechanotransductionMesenchymal stromal cells

Identifiers

PMID34365041
PMCPMC8497430
OpenAlexW3187532513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.